tiprankstipranks
Terminalcare Support Institute, Inc. (JP:7362)
:7362
Japanese Market
Want to see JP:7362 full AI Analyst Report?

Terminalcare Support Institute, Inc. (7362) AI Stock Analysis

0 Followers

Top Page

JP:7362

Terminalcare Support Institute, Inc.

(7362)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
¥905.00
▲(13.27% Upside)
Action:Reiterated
Date:06/11/26
The score is held back primarily by weakening profitability, rising leverage, and sustained negative free cash flow. Technicals are supportive with price above key moving averages, but momentum appears overbought, adding near-term risk. Valuation is moderate based on the P/E, with no dividend yield data to improve the outlook.
Positive Factors
Consistent revenue growth (2020–2025)
Sustained top-line expansion across multiple years and a clear step-up in 2022 indicate durable demand and expanding service scale in its core care-facilities business. Persistent revenue growth supports long-term capacity utilization, strategic reinvestment and revenue resilience.
Negative Factors
Rising leverage (debt-to-equity ~2.5x)
A material rise in leverage over a short period reduces financial flexibility and raises refinancing and interest-rate vulnerability. Higher debt levels constrain strategic choices, increase fixed obligations, and heighten bankruptcy risk if operating performance deteriorates further.
Read all positive and negative factors
Positive Factors
Negative Factors
Consistent revenue growth (2020–2025)
Sustained top-line expansion across multiple years and a clear step-up in 2022 indicate durable demand and expanding service scale in its core care-facilities business. Persistent revenue growth supports long-term capacity utilization, strategic reinvestment and revenue resilience.
Read all positive factors

Terminalcare Support Institute, Inc. (7362) vs. iShares MSCI Japan ETF (EWJ)

Terminalcare Support Institute, Inc. Business Overview & Revenue Model

Company Description
Terminalcare Support Institute Inc., established in 2010 and based in Kyoto, Japan, specializes in offering a comprehensive suite of eldercare services throughout Japan. These services encompass in-home care, preventative health initiatives, direc...

Terminalcare Support Institute, Inc. Financial Statement Overview

Summary
Revenue growth has been consistent, but profitability has weakened sharply with notable margin compression in 2025. Leverage has increased materially (debt-to-equity rising to ~2.5x by 2025), and cash generation is a major concern with deeply negative free cash flow for three consecutive years (2023–2025).
Income Statement
56
Neutral
Balance Sheet
44
Neutral
Cash Flow
29
Negative
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue4.78B4.89B4.71B4.25B4.10B3.40B
Gross Profit651.77M626.27M664.67M646.76M685.84M599.50M
EBITDA240.34M205.09M250.59M196.83M262.62M247.27M
Net Income86.90M81.97M113.77M126.67M157.54M138.03M
Balance Sheet
Total Assets5.32B5.81B4.80B4.09B3.05B2.89B
Cash, Cash Equivalents and Short-Term Investments887.13M1.19B1.13B1.38B1.09B874.72M
Total Debt3.26B3.58B2.81B2.26B1.22B1.43B
Total Liabilities4.00B4.39B3.49B2.90B1.96B1.96B
Stockholders Equity1.32B1.41B1.31B1.19B1.08B927.37M
Cash Flow
Free Cash Flow0.00-691.25M-780.73M-562.25M317.64M-56.66M
Operating Cash Flow0.00287.23M304.51M238.18M812.73M462.19M
Investing Cash Flow0.00-1.01B-1.10B-836.33M-510.68M-523.54M
Financing Cash Flow0.00771.09M545.64M892.46M-90.11M523.02M

Terminalcare Support Institute, Inc. Technical Analysis

Technical Analysis Sentiment
Neutral
Last Price799.00
Price Trends
50DMA
826.30
Positive
100DMA
816.04
Positive
200DMA
820.46
Positive
Market Momentum
MACD
18.71
Negative
RSI
50.23
Neutral
STOCH
26.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:7362, the sentiment is Neutral. The current price of 799 is below the 20-day moving average (MA) of 833.05, below the 50-day MA of 826.30, and below the 200-day MA of 820.46, indicating a bullish trend. The MACD of 18.71 indicates Negative momentum. The RSI at 50.23 is Neutral, neither overbought nor oversold. The STOCH value of 26.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:7362.

Terminalcare Support Institute, Inc. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
72
Outperform
¥2.91B6.122.82%5.16%19.94%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
51
Neutral
¥1.29B10.909.08%30.71%
51
Neutral
¥5.54B52.874.07%4.85%-85.27%
51
Neutral
¥2.56B22.242.56%-6.54%-69.23%
46
Neutral
¥4.83B15.921.41%16.83%-45.33%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:7362
Terminalcare Support Institute, Inc.
844.00
77.00
10.04%
JP:2373
Care Twentyone Corporation
412.00
26.05
6.75%
JP:2425
Care Service Co., Ltd.
675.00
-91.97
-11.99%
JP:7061
Japan Hospice Holdings Inc.
571.00
-640.58
-52.87%
JP:9220
FB CARE SERVICE CO.,LTD.
1,196.00
224.34
23.09%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 11, 2026